Azura Ophthalmics Presents Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics presents positive Phase 2b data of AZR-MD-001 in Meibomian Gland Dysfunction at Ophthalmology Innovation Summit XII.